Literature DB >> 17069560

Refractive eye surgery in treating functional amblyopia in children.

Samuel Levenger1, Pinhas Nemet, Ami Hirsh, Israel Kremer, Arie Nemet.   

Abstract

PURPOSE: While excimer laser refractive surgery is recommended and highly successful for correcting refractive errors in adults, its use in children has not been extensively exercised or studied. We report our experience treating children with amblyopia due to high anisometropia, high astigmatism, high myopia and with associated developmental delay.
SETTING: Review of patient records of our refractive clinic.
METHODS: A retrospective review was made of all 11 children with stable refractive errors who were unsuccessfully treated non-surgically and then underwent corneal refractive surgery and in one case, lenticular surgery. Seven had high myopic anisometropia, 2 had high astigmatism, and two had high myopia--one with Down's Syndrome and one with agenesis of the corpus callosum.
RESULTS: The surgical refractive treatment eliminated or reduced the anisometropia, reduced the astigmatic error, improved vision and improved the daily function of the children with developmental delay. There were no complications or untoward results.
CONCLUSIONS: Refractive surgery is safe and effective in treating children with high myopic anisometropia, high astigmatism, high myopia and developmental delay due to the resulting poor vision. Surgery can improve visual acuity in amblyopia not responding to routine treatment by correcting the refractive error and refractive aberrations.

Entities:  

Mesh:

Year:  2006        PMID: 17069560

Source DB:  PubMed          Journal:  Binocul Vis Strabismus Q        ISSN: 1088-6281


  2 in total

1.  Excimer laser refractive surgery rate in Iran: 2010-2014.

Authors:  Hassan Hashemi; Abbasali Yekta; Marzieh Nojomi; Saman Mohazzab-Torabi; Bardia Behnia; Mehdi Khabazkhoob
Journal:  J Curr Ophthalmol       Date:  2017-06-01

Review 2.  How to help children with neurodevelopmental and visual problems: a scoping review.

Authors:  C Williams; K Northstone; C Borwick; M Gainsborough; J Roe; S Howard; S Rogers; J Amos; J M Woodhouse
Journal:  Br J Ophthalmol       Date:  2013-10-24       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.